4p16.3 copy number variation (WP5365)

Homo sapiens

The Wolf-Hirschhorn syndrome is a rare genetic disorder caused by a microdeletion in the chromosomal region 4p16.3. Typical symptoms are a distinct facial morphology, intellectual disability, psychiatric disorders, seizures, and heart defects. The chromosomal position chr4:1,552,030-2,091,303 (GCRh37) was taken from Kirov et al. 2014 and literature cited there (10.1016/j.biopsych.2013.07.022).

Authors

Ewoud , Friederike Ehrhart , Kristina Hanspers , Eric Weitz , and Egon Willighagen

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Rare Diseases

Annotations

Pathway Ontology

disease pathway

Disease Ontology

disease of mental health

Participants

Label Type Compact URI Comment
N-acetyl-L-aspartate Metabolite chebi:16953
Ca2+ Metabolite chebi:29108
Acetyl-CoA Metabolite chebi:57288
L-aspartate Metabolite chebi:29991
proton Metabolite chebi:24636
K+ Metabolite chebi:29103
Methamphetamine Metabolite chebi:6809
Inositol 1,4,5-trisphosphate Metabolite chebi:16595
SCARNA22 GeneProduct ensembl:ENSG00000249784
NELFA GeneProduct ensembl:ENSG00000185049 WHSC2
CKAP5 GeneProduct ensembl:ENSG00000175216
H3F3A GeneProduct ncbigene:3020
NELFCD GeneProduct ensembl:ENSG00000101158
NELFE GeneProduct ensembl:ENSG00000204356
FGF2 GeneProduct ensembl:ENSG00000138685
FAM53A GeneProduct ensembl:ENSG00000174137
CBL GeneProduct ensembl:ENSG00000110395
MAPK3 GeneProduct ensembl:ENSG00000102882
ERI1 GeneProduct ensembl:ENSG00000104626
TACC3 GeneProduct ensembl:ENSG00000013810
CLTCL1 GeneProduct ensembl:ENSG00000070371
NSD2 GeneProduct ensembl:ENSG00000109685
NAT8L GeneProduct ensembl:ENSG00000185818
SLBP GeneProduct ensembl:ENSG00000163950
NELFB GeneProduct ensembl:ENSG00000188986
TMEM129 GeneProduct ensembl:ENSG00000168936
MIR943 GeneProduct ensembl:ENSG00000284587
C4orf48 GeneProduct ensembl:ENSG00000243449
POLN GeneProduct ensembl:ENSG00000130997
FGFR3 GeneProduct ensembl:ENSG00000068078
UBE2J2 GeneProduct ensembl:ENSG00000160087
BCS1L GeneProduct ensembl:ENSG00000074582
MAPK1 GeneProduct ensembl:ENSG00000100030
LETM1 GeneProduct ensembl:ENSG00000168924
FRS2 GeneProduct ensembl:ENSG00000166225
PLCG1 GeneProduct ensembl:ENSG00000124181
GRB2 GeneProduct ensembl:ENSG00000177885
SOS1 GeneProduct ensembl:ENSG00000115904
PIK3R1 GeneProduct ensembl:ENSG00000145675
GAB1 GeneProduct ensembl:ENSG00000109458
NELFA GeneProduct ensembl:ENSG00000185049
Core histone H2A/H2B/H3/H4 Protein pfam:PF00125
Linker histone H1 and H5 family Protein pfam:PF00538

References

  1. The protein that binds the 3’ end of histone mRNA: a novel RNA-binding protein required for histone pre-mRNA processing. Wang ZF, Whitfield ML, Ingledue TC 3rd, Dominski Z, Marzluff WF. Genes Dev. 1996 Dec 1;10(23):3028–40. PubMed Europe PMC Scholia
  2. The gene for histone RNA hairpin binding protein is located on human chromosome 4 and encodes a novel type of RNA binding protein. Martin F, Schaller A, Eglite S, Schümperli D, Müller B. EMBO J. 1997 Feb 17;16(4):769–78. PubMed Europe PMC Scholia
  3. NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation. Yamaguchi Y, Takagi T, Wada T, Yano K, Furuya A, Sugimoto S, et al. Cell. 1999 Apr 2;97(1):41–51. PubMed Europe PMC Scholia
  4. Mapping the Wolf-Hirschhorn syndrome phenotype outside the currently accepted WHS critical region and defining a new critical region, WHSCR-2. Zollino M, Lecce R, Fischetto R, Murdolo M, Faravelli F, Selicorni A, et al. Am J Hum Genet. 2003 Mar;72(3):590–7. PubMed Europe PMC Scholia
  5. Phosphorylation of stem-loop binding protein (SLBP) on two threonines triggers degradation of SLBP, the sole cell cycle-regulated factor required for regulation of histone mRNA processing, at the end of S phase. Zheng L, Dominski Z, Yang XC, Elms P, Raska CS, Borchers CH, et al. Mol Cell Biol. 2003 Mar;23(5):1590–601. PubMed Europe PMC Scholia
  6. Human transcription elongation factor NELF: identification of novel subunits and reconstitution of the functionally active complex. Narita T, Yamaguchi Y, Yano K, Sugimoto S, Chanarat S, Wada T, et al. Mol Cell Biol. 2003 Mar;23(6):1863–73. PubMed Europe PMC Scholia
  7. Characterization of the mitochondrial protein LETM1, which maintains the mitochondrial tubular shapes and interacts with the AAA-ATPase BCS1L. Tamai S, Iida H, Yokota S, Sayano T, Kiguchiya S, Ishihara N, et al. J Cell Sci. 2008 Aug 1;121(Pt 15):2588–600. PubMed Europe PMC Scholia
  8. Evidence for mitochondrial and cytoplasmic N-acetylaspartate synthesis in SH-SY5Y neuroblastoma cells. Arun P, Moffett JR, Namboodiri AMA. Neurochem Int. 2009 Sep;55(4):219–25. PubMed Europe PMC Scholia
  9. Genome-wide RNAi screen identifies Letm1 as a mitochondrial Ca2+/H+ antiporter. Jiang D, Zhao L, Clapham DE. Science. 2009 Oct 2;326(5949):144–7. PubMed Europe PMC Scholia
  10. Molecular identification of aspartate N-acetyltransferase and its mutation in hypoacetylaspartia. Wiame E, Tyteca D, Pierrot N, Collard F, Amyere M, Noel G, et al. Biochem J. 2009 Dec 14;425(1):127–36. PubMed Europe PMC Scholia
  11. The target of the NSD family of histone lysine methyltransferases depends on the nature of the substrate. Li Y, Trojer P, Xu CF, Cheung P, Kuo A, Drury WJ 3rd, et al. J Biol Chem. 2009 Dec 4;284(49):34283–95. PubMed Europe PMC Scholia
  12. Methamphetamine-induced neuronal protein NAT8L is the NAA biosynthetic enzyme: implications for specialized acetyl coenzyme A metabolism in the CNS. Ariyannur PS, Moffett JR, Manickam P, Pattabiraman N, Arun P, Nitta A, et al. Brain Res. 2010 Jun 4;1335:1–13. PubMed Europe PMC Scholia
  13. C4ORF48, a gene from the Wolf-Hirschhorn syndrome critical region, encodes a putative neuropeptide and is expressed during neocortex and cerebellar development. Endele S, Nelkenbrecher C, Bördlein A, Schlickum S, Winterpacht A. Neurogenetics. 2011 May;12(2):155–63. PubMed Europe PMC Scholia
  14. A TACC3/ch-TOG/clathrin complex stabilises kinetochore fibres by inter-microtubule bridging. Booth DG, Hood FE, Prior IA, Royle SJ. EMBO J. 2011 Mar 2;30(5):906–19. PubMed Europe PMC Scholia
  15. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming. Kuo AJ, Cheung P, Chen K, Zee BM, Kioi M, Lauring J, et al. Mol Cell. 2011 Nov 18;44(4):609–20. PubMed Europe PMC Scholia
  16. Structure of histone mRNA stem-loop, human stem-loop binding protein, and 3’hExo ternary complex. Tan D, Marzluff WF, Dominski Z, Tong L. Science. 2013 Jan 18;339(6117):318–21. PubMed Europe PMC Scholia
  17. Specific removal of TACC3-ch-TOG-clathrin at metaphase deregulates kinetochore fiber tension. Cheeseman LP, Harry EF, McAinsh AD, Prior IA, Royle SJ. J Cell Sci. 2013 May 1;126(Pt 9):2102–13. PubMed Europe PMC Scholia
  18. Functional reconstitution of the mitochondrial Ca2+/H+ antiporter Letm1. Tsai MF, Jiang D, Zhao L, Clapham D, Miller C. J Gen Physiol. 2014 Jan;143(1):67–73. PubMed Europe PMC Scholia
  19. A high-coverage shRNA screen identifies TMEM129 as an E3 ligase involved in ER-associated protein degradation. van de Weijer ML, Bassik MC, Luteijn RD, Voorburg CM, Lohuis MAM, Kremmer E, et al. Nat Commun. 2014 May 8;5:3832. PubMed Europe PMC Scholia
  20. NCLX protein, but not LETM1, mediates mitochondrial Ca2+ extrusion, thereby limiting Ca2+-induced NAD(P)H production and modulating matrix redox state. De Marchi U, Santo-Domingo J, Castelbou C, Sekler I, Wiederkehr A, Demaurex N. J Biol Chem. 2014 Jul 18;289(29):20377–85. PubMed Europe PMC Scholia
  21. How a homolog of high-fidelity replicases conducts mutagenic DNA synthesis. Lee YS, Gao Y, Yang W. Nat Struct Mol Biol. 2015 Apr;22(4):298–303. PubMed Europe PMC Scholia
  22. Structure of the Epigenetic Oncogene MMSET and Inhibition by N-Alkyl Sinefungin Derivatives. Tisi D, Chiarparin E, Tamanini E, Pathuri P, Coyle JE, Hold A, et al. ACS Chem Biol. 2016 Nov 18;11(11):3093–105. PubMed Europe PMC Scholia
  23. PINK1-mediated phosphorylation of LETM1 regulates mitochondrial calcium transport and protects neurons against mitochondrial stress. Huang E, Qu D, Huang T, Rizzi N, Boonying W, Krolak D, et al. Nat Commun. 2017 Nov 9;8(1):1399. PubMed Europe PMC Scholia
  24. Depletion of Nsd2-mediated histone H3K36 methylation impairs adipose tissue development and function. Zhuang L, Jang Y, Park YK, Lee JE, Jain S, Froimchuk E, et al. Nat Commun. 2018 May 4;9(1):1796. PubMed Europe PMC Scholia
  25. Loss-of-function and missense variants in NSD2 cause decreased methylation activity and are associated with a distinct developmental phenotype. Zanoni P, Steindl K, Sengupta D, Joset P, Bahr A, Sticht H, et al. Genet Med. 2021 Aug;23(8):1474–83. PubMed Europe PMC Scholia
  26. Bi-allelic LETM1 variants perturb mitochondrial ion homeostasis leading to a clinical spectrum with predominant nervous system involvement. Kaiyrzhanov R, Mohammed SEM, Maroofian R, Husain RA, Catania A, Torraco A, et al. Am J Hum Genet. 2022 Sep 1;109(9):1692–712. PubMed Europe PMC Scholia
  27. TMBIM5 is the Ca2+ /H+ antiporter of mammalian mitochondria. Austin S, Mekis R, Mohammed SEM, Scalise M, Wang WA, Galluccio M, et al. EMBO Rep. 2022 Dec 6;23(12):e54978. PubMed Europe PMC Scholia